Apricus Wealth, LLC Relmada Therapeutics, Inc. Transaction History
Apricus Wealth, LLC
- $162 Million
- Q1 2025
A detailed history of Apricus Wealth, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Apricus Wealth, LLC holds 48,962 shares of RLMD stock, worth $15,667. This represents 0.01% of its overall portfolio holdings.
Number of Shares
48,962
Previous 48,962
-0.0%
Holding current value
$15,667
Previous $25,000
48.0%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding RLMD
# of Institutions
55Shares Held
8.32MCall Options Held
364KPut Options Held
46.5K-
Franklin Resources Inc San Mateo, CA1.3MShares$416,6880.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$402,1450.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.23MShares$392,9360.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$183,4600.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA495KShares$158,4460.04% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $9.15M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...